Ye-xiong X. Li

Five-Year Outcomes of Short-Term Radiotherapy Plus Chemotherapy Versus Long-Term Chemoradiotherapy for Locally Advanced Rectal Cancer: Updated Results of the STELLAR Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: July 27, 2026

A study of parent-of-origin effect of single nucleotide polymorphisms of imprinted gene KCNQ1 on risk for hypertension

Journal: Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi

Published: July 27, 2026

Metabolic profiles in umbilical cord blood associated with neonatal brain injury in selective fetal growth restriction

Journal: Zhonghua yi xue za zhi

Published: June 29, 2026

Comparative analysis of prognostic performance among different lymph node staging systems in gastric cancer

Journal: Zhonghua zhong liu za zhi [Chinese journal of oncology]

Published: May 18, 2026

Extranodal natural killer/T-cell lymphoma: From fatal to curable.

Journal: CA: a cancer journal for clinicians

Published: March 04, 2026

Prognostic and Treatment Values of Baseline Metabolic Tumor Volume in Early-stage Extranodal NK/T-cell Lymphoma in the Modern Treatment Era.

Journal: International journal of radiation oncology, biology, physics

Published: February 14, 2026

Integrated Genomic and Proteomic Analysis Reveals T-B Lymphocyte Signatures in the MYCN Driven "Immune Desert" of Specific Neuroblastoma Subtypes.

Journal: CNS neuroscience & therapeutics

Published: January 17, 2026

Risk-Adapted Combined-Modality Therapy in Early-Stage Extranodal Natural Killer-/T-Cell Lymphoma: A Markov Model-Based Cost-Effectiveness Analysis.

Journal: JCO global oncology

Published: January 15, 2026

Dosimetric Impact and Correction of Lipiodol Deposition on Photon-Beam Radiotherapy for Hepatocellular Carcinoma Using a Novel Simulation Model.

Journal: Journal of hepatocellular carcinoma

Published: January 03, 2026

Parent-of-origin effects of FGF/FGFR signaling pathway candidate gene polymorphisms on the risk of non-syndromic cleft lip with or without cleft palate

Journal: Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi

Published: December 24, 2025

Magnetic resonance-guided simultaneous multi-focal adaptive radiotherapy for prostate, pElvis & metastases (MRgSMART-PEM) in prostate cancer: a prospective phase II study.

Journal: Radiation oncology (London, England)

Published: November 29, 2025

Failure patterns and clinical indications in early-stage follicular lymphoma: a study from the National Cancer Center in China.

Journal: Frontiers in pharmacology

Published: November 12, 2025

Five-Year Outcomes of Short-Term Radiotherapy Plus Chemotherapy Versus Long-Term Chemoradiotherapy for Locally Advanced Rectal Cancer: Updated Results of the STELLAR Trial.

Five-Year Outcomes of Short-Term Radiotherapy Plus Chemotherapy Versus Long-Term Chemoradiotherapy for Locally Advanced Rectal Cancer: Updated Results of the STELLAR Trial.

A study of parent-of-origin effect of single nucleotide polymorphisms of imprinted gene KCNQ1 on risk for hypertension

A study of parent-of-origin effect of single nucleotide polymorphisms of imprinted gene KCNQ1 on risk for hypertension

Metabolic profiles in umbilical cord blood associated with neonatal brain injury in selective fetal growth restriction

Metabolic profiles in umbilical cord blood associated with neonatal brain injury in selective fetal growth restriction

Comparative analysis of prognostic performance among different lymph node staging systems in gastric cancer

Comparative analysis of prognostic performance among different lymph node staging systems in gastric cancer

Extranodal natural killer/T-cell lymphoma: From fatal to curable.

Extranodal natural killer/T-cell lymphoma: From fatal to curable.

Prognostic and Treatment Values of Baseline Metabolic Tumor Volume in Early-stage Extranodal NK/T-cell Lymphoma in the Modern Treatment Era.

Prognostic and Treatment Values of Baseline Metabolic Tumor Volume in Early-stage Extranodal NK/T-cell Lymphoma in the Modern Treatment Era.

Integrated Genomic and Proteomic Analysis Reveals T-B Lymphocyte Signatures in the MYCN Driven "Immune Desert" of Specific Neuroblastoma Subtypes.

Integrated Genomic and Proteomic Analysis Reveals T-B Lymphocyte Signatures in the MYCN Driven "Immune Desert" of Specific Neuroblastoma Subtypes.

Risk-Adapted Combined-Modality Therapy in Early-Stage Extranodal Natural Killer-/T-Cell Lymphoma: A Markov Model-Based Cost-Effectiveness Analysis.

Risk-Adapted Combined-Modality Therapy in Early-Stage Extranodal Natural Killer-/T-Cell Lymphoma: A Markov Model-Based Cost-Effectiveness Analysis.

Dosimetric Impact and Correction of Lipiodol Deposition on Photon-Beam Radiotherapy for Hepatocellular Carcinoma Using a Novel Simulation Model.

Dosimetric Impact and Correction of Lipiodol Deposition on Photon-Beam Radiotherapy for Hepatocellular Carcinoma Using a Novel Simulation Model.

Parent-of-origin effects of FGF/FGFR signaling pathway candidate gene polymorphisms on the risk of non-syndromic cleft lip with or without cleft palate

Parent-of-origin effects of FGF/FGFR signaling pathway candidate gene polymorphisms on the risk of non-syndromic cleft lip with or without cleft palate

Magnetic resonance-guided simultaneous multi-fo​cal adaptive radiotherapy for prostate, pElvis & metastases (MRgSMART-PEM) in prostate cancer: a prospective phase II study.

Magnetic resonance-guided simultaneous multi-fo​cal adaptive radiotherapy for prostate, pElvis & metastases (MRgSMART-PEM) in prostate cancer: a prospective phase II study.

Failure patterns and clinical indications in early-stage follicular lymphoma: a study from the National Cancer Center in China.

Failure patterns and clinical indications in early-stage follicular lymphoma: a study from the National Cancer Center in China.

Magnetic resonance-guided simultaneous multi-focal adaptive radiotherapy for prostate, pElvis & metastases (MRgSMART-PEM) in prostate cancer: a prospective phase II study.

Magnetic resonance-guided simultaneous multi-focal adaptive radiotherapy for prostate, pElvis & metastases (MRgSMART-PEM) in prostate cancer: a prospective phase II study.